| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/03/2009 | US20090298760 Modified Coagulation Factor VIIa With Extended Half-Life |
| 12/03/2009 | US20090298759 C-Reactive Protein and Its Use to Treat Systemic Lupus Erythematosus and Related Conditions |
| 12/03/2009 | US20090298758 Thymosin beta 4 derivatives and use thereof |
| 12/03/2009 | US20090298757 Oxyntomodulin analogues and their effects on feeding behaviour |
| 12/03/2009 | US20090298756 Functions and uses of gpr39 gene in mammalian central nervous system |
| 12/03/2009 | US20090298754 Hai-1 and hai-2 in cancer therapy |
| 12/03/2009 | US20090298746 Pegylated hemoglobin and albumin and uses thereof |
| 12/03/2009 | US20090298713 Polynucleotides which are of nature b2/d+ a- and which are isolated from e. coli, and biological uses of these polynucleotides and of their polypeptides |
| 12/03/2009 | US20090298167 Interleukin-21 receptor binding proteins |
| 12/03/2009 | US20090298099 Gonococcal Proteins and Nucleic Acids |
| 12/03/2009 | US20090298085 Using presence of bcl-2 gene translocation as evaluative tool in prognosing/diagnosing breast cancer |
| 12/03/2009 | US20090298080 METHODS AND REAGENTS FOR DETECTING CpG METHYLATION WITH A METHYL CpG BINDING PROTEIN (MBP) |
| 12/03/2009 | US20090298079 High affinity binding site of hgfr and methods for identification of antagonists thereof |
| 12/03/2009 | US20090298073 Kidney Toxicity Biomarkers |
| 12/03/2009 | US20090298046 Assays for Histone Deacetylase 1/2 Selective Inhibitors |
| 12/03/2009 | US20090297689 Peptidylarginine deiminase and uses thereof in the production of citrullinated proteins and peptides |
| 12/03/2009 | US20090297657 O-acetylhomoserinesulfhydorelace gene and use thereof |
| 12/03/2009 | US20090297639 Cosmetic treatement method for fighting against skin ageing effects |
| 12/03/2009 | US20090297607 Biomimetic polymers and uses thereof |
| 12/03/2009 | US20090297563 Diagnosis And Treatment of Immune-Related Diseases |
| 12/03/2009 | US20090297557 Human parvovirus: bocavirus |
| 12/03/2009 | US20090297550 Chloroplast-derived human vaccine antigens against malaria |
| 12/03/2009 | US20090297549 Conserved and specific streptococcal genomes |
| 12/03/2009 | US20090297548 Immunogenic compositions comprising anthrax spore-associated proteins |
| 12/03/2009 | US20090297547 Pharmaceutical composition containing the nmb0938 protein |
| 12/03/2009 | US20090297545 Immunomodulatory dairy peptides and uses thereof |
| 12/03/2009 | US20090297544 Novel tumor antigen protein sart-3 and tumor antigen peptides thereof |
| 12/03/2009 | US20090297543 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof |
| 12/03/2009 | US20090297542 Adp-ribosylating toxin from listeria monocytogenes |
| 12/03/2009 | US20090297536 Compositions, kits, and methods for identification, assessment, prevention and therapy of cancer |
| 12/03/2009 | US20090297531 Compositions and methods for the diagnosis and treatment of tumor |
| 12/03/2009 | US20090297527 Binding Domains of Proteins of the Repulsive Guidance Molecule (RGM) Protein Family and Functional Fragments Thereof, and Their Use |
| 12/03/2009 | US20090297516 Engineered lectins for viral inactivation |
| 12/03/2009 | US20090297511 Prevention and treatment of amyloidogenic disease |
| 12/03/2009 | US20090297504 Bcma polypeptides and uses thereof |
| 12/03/2009 | US20090297483 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 12/03/2009 | US20090297482 Probiotic strain and antimicrobial peptide derived therefrom |
| 12/03/2009 | US20090297440 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/03/2009 | DE102008025935A1 Verfahren zur Herstellung eines konzentrierten modifizierten Weizenproteins A process for preparing a concentrated modified wheat protein |
| 12/03/2009 | CA2726256A1 Variant hhip1 protein and methods and uses thereof |
| 12/03/2009 | CA2725983A1 Linezolid resistance mutations in gram-positive bacteria |
| 12/03/2009 | CA2725613A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 12/03/2009 | CA2725100A1 Method for efficiently amplifying abnormal prion protein derived from bse |
| 12/03/2009 | CA2712101A1 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
| 12/03/2009 | CA2710040A1 A soluble tumor necrosis factor receptor mutant |
| 12/02/2009 | EP2128268A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 12/02/2009 | EP2128267A2 Methods of evaluating phosphatase inhibitors |
| 12/02/2009 | EP2128261A1 A recombinant adenovirus comprising recombinant khp50 gene and preparation method and uses thereof |
| 12/02/2009 | EP2128260A2 Modified TGF-beta superfamily proteins |
| 12/02/2009 | EP2128259A1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging |
| 12/02/2009 | EP2128257A2 Mutation of the parkin gene, compositions, methods and uses |
| 12/02/2009 | EP2128256A2 Molecular clones with mutated HIV GAG/POL, SIV GAG and SIV ENV genes |
| 12/02/2009 | EP2128251A1 Genes having activity of promoting endoreduplication |
| 12/02/2009 | EP2128246A1 Methods and composition for the production of orthoganal tRNA-Aminoacyl-tRNA synthetase pairs |
| 12/02/2009 | EP2128174A1 Multimeric forms of TNF superfamily ligands |
| 12/02/2009 | EP2128172A1 Preparation process of recombinant human p43 protein |
| 12/02/2009 | EP2127679A1 SlpA as a tool for recombinant protein and enzyme technology |
| 12/02/2009 | EP2127678A1 SlpA as a tool for recombinant protein and enzyme technology |
| 12/02/2009 | EP2127672A1 Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof |
| 12/02/2009 | EP2127671A1 Therapeutic agent for cancer |
| 12/02/2009 | EP2127666A1 Method for the treatment or prophylaxis of chronic inflammatory diseases |
| 12/02/2009 | EP2127664A1 Change of the load state of MHC molecules by dipeptides |
| 12/02/2009 | EP2126583A1 Diagnosis of collagen ix destruction |
| 12/02/2009 | EP2126106A1 Process for producing and purifying factor viii and its derivatives |
| 12/02/2009 | EP2126092A2 Fusion proteins binding to growth factors |
| 12/02/2009 | EP2126086A1 Transcription factor for killer cell activation, differentiation and uses thereof |
| 12/02/2009 | EP2126084A1 Polynucleotide sequence for the inhibition of phospholamban synthesis |
| 12/02/2009 | EP2126076A1 Proteins from the webs of nephilengys cruentata, avicularia juruensis and parawixia bistriata spiders |
| 12/02/2009 | EP2126051A1 A method for expanding monocytes |
| 12/02/2009 | EP2125885A2 Novel viii factors for the treatment of type a hemophilia |
| 12/02/2009 | EP2125884A2 Variants derived from actriib and uses therefor |
| 12/02/2009 | EP2125883A2 Regulatory t cell epitopes, compositions and uses thereof |
| 12/02/2009 | EP2125882A1 Tumor suppressor activating polypeptides and uses thereof |
| 12/02/2009 | EP2125881A1 Proteins and/or peptides for the prevention and/or treatment of neurodegenerative diseases |
| 12/02/2009 | EP2125880A1 Soluble il-17ra/rc fusion proteins and related methods |
| 12/02/2009 | EP2125879A2 Immune system mediator |
| 12/02/2009 | EP2125877A1 Plant derived antibiotic peptide rich in glycine |
| 12/02/2009 | EP2125876A1 Tighter-binding c-peptide inhibitors of hiv-1 entry |
| 12/02/2009 | EP2125874A1 Polypeptide comprising a knottin protein moiety |
| 12/02/2009 | EP2125872A1 Basic peptides and their use as combined antibacterial-antifungine agents |
| 12/02/2009 | EP2125870A1 Inhibitors of hepatitis c ns3 protease |
| 12/02/2009 | EP2125868A2 Brachyury polypeptides and methods for use |
| 12/02/2009 | EP2125866A1 Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules |
| 12/02/2009 | EP2125861A2 Method of purifying apolipoprotein a-1 |
| 12/02/2009 | EP2125005A2 Prame derived peptides and immunogenic compositions comprising these |
| 12/02/2009 | EP2124994A2 Soluble fc gamma r1a for reducing inflammation |
| 12/02/2009 | EP2124988A2 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease |
| 12/02/2009 | EP2124974A2 Glucagon analogs exhibiting enhanced solubility in physiological ph buffers |
| 12/02/2009 | EP2124548A2 Disintegrin variants and pharmaceutical uses thereof |
| 12/02/2009 | EP2124522A1 Putative cytokinin receptor and methods for use thereof |
| 12/02/2009 | EP1732951B1 Monoclonal antibodies with specificity for fetal erythroid cells |
| 12/02/2009 | EP1716169B1 Ornithobacterium rhinotracheale subunit vaccines |
| 12/02/2009 | EP1664100B1 Lawsonia intracellularis subunit vaccine |
| 12/02/2009 | EP1625221B1 Method for the preparation of transgenic plants characterised by geminivirus lasting resistance |
| 12/02/2009 | EP1555324B1 Defructosylation method |
| 12/02/2009 | EP1436425B1 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
| 12/02/2009 | EP1180041B2 Vaccine against isa virus |
| 12/02/2009 | EP1142997B1 Novel rhodococcus, rhodococcus-origin nitrilase gene, nitrilehydratase gene and amidase gene and process for producing carboxylic acids by using the same |
| 12/02/2009 | EP0748386B2 Production of fibrinogen in transgenic animals |
| 12/02/2009 | CN101595222A Plants having enhanced seed yield-related traits and a method for making the same |